Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Online Reports

Volume 25—2019

Volume 25, Number 3—March 2019

image of the "Thumbnail" version of the Volume 25, Number 3—March 2019 cover of the CDC"s EID journal
Survey on Implementation of One Health Approach for MERS-CoV Preparedness and Control in Gulf Cooperation Council and Middle East Countries PDF Version[PDF - 612 KB - 6 pages]
E. Farag et al.
    View Abstract

In 2015, a One Health Working Group was established in Qatar to conduct a survey in the Gulf Cooperation Council countries, Egypt, and Jordan to monitor preparedness of public health and veterinary health authorities in response to the Middle East respiratory syndrome coronavirus epidemic. All but 1 country indicated they established joint One Health policy teams for investigation and response. However, the response to the questionnaires was largely limited to veterinary authorities. Critical barriers and limitations were identified. National and regional leaders, policy makers, and stakeholders should be prompted to advocate and enhance adoption of the One Health framework to mitigate the risk for Middle East respiratory syndrome and other emerging zoonotic diseases.

        Email Email this Article

Volume 25, Number 2—February 2019

image of the "Thumbnail" version of the Volume 25, Number 2—February 2019 cover of the CDC"s EID journal
Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union PDF Version[PDF - 679 KB - 8 pages]
A. Navarro-Torné et al.
    View Abstract

Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health.

        Email Email this Article